Survodutide
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Boehringer Ingelheim · Phase 3 · Not yet recruiting · Enrollment 600
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Survodutide arm | n/r | n/r | n/r | n/r |
| Placebo arm | n/r | n/r | n/r | n/r |
Not shown
- Survodutide arm: endpoint not reported
- Placebo arm: endpoint not reported